To drive life and health sciences development in Hong Kong, speakers of the session will give a presentation to the ecosystem stakeholders to deepen the understanding on how a global Contract Research, Development and Manufacturing Organization (CRDMO) can help facilitate drug development.
Speakers:
• Mr Edward Au, Deloitte China Southern Region Managing Partner
• Mr Andy Wong, Head of Innovation and Technology, Invest Hong Kong
• Dr Grace Lau, Head, Institute for Translational Research, Hong Kong Science and Technology Park
• Dr Ronni Zhu, Associate Director, Business Development, APAC, WuXi Biologics
• Dr George Wang, Vice President, Biologics Innovation & Discovery, WuXi Biologics
Organisers:
Invest Hong Kong, Deloitte
Co-organiser:
Hong Kong Science and Technology Parks Corporation
